E
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A73.4 KBEPIRUS Biopharmaceuticals, Inc.Feb 14, 12:05 PM ET·0001654954-17-001048
- 8-K19.6 KBEPIRUS Biopharmaceuticals, Inc.Aug 1, 1:40 PM ET·0001104659-16-135667
- 8-K24.6 KBEPIRUS Biopharmaceuticals, Inc.Jul 25, 11:31 AM ET·0001104659-16-134031
- SC 13G/A9.3 KBEPIRUS Biopharmaceuticals, Inc.Jul 11, 2:57 PM ET·0001137774-16-000252
- SC 13G/A8.7 KBEPIRUS Biopharmaceuticals, Inc.Jul 11, 12:07 PM ET·0000315066-16-006007
- SC 13G/A9.0 KBEPIRUS Biopharmaceuticals, Inc.Jul 8, 11:02 AM ET·0000053417-16-000384
- 8-K27.0 KBEPIRUS Biopharmaceuticals, Inc.Jul 1, 5:22 PM ET·0001104659-16-130852
- 8-K22.0 KBEPIRUS Biopharmaceuticals, Inc.Jun 14, 4:06 PM ET·0001104659-16-127110
- 46.6 KBEPIRUS Biopharmaceuticals, Inc.May 31, 4:52 PM ET·0001104659-16-124527
- 46.6 KBEPIRUS Biopharmaceuticals, Inc.May 31, 4:51 PM ET·0001104659-16-124526
Insiders
10- 5AM VENTURES III, L.P.10% Owner
- ALDRICH RICHARDDirector
- ANGIOTECH PHARMACEUTICALS INC10% Owner
- Aurentz VincentChief Business Officer
- BAIRD LYNN GSenior VP - Regulatory Affairs
- BIOTECHNOLOGY VALUE FUND L PDirect Beneficial Owner
- BONDERMAN DAVID10% Owner
- Borisy AlexisDirector, CEO & President
- BUCHI J KEVINDirector
- BVF INC/IL10% Owner
Tickers
No tickers on record
Addresses
business
699 BOYLSTON ST 8TH FLOOR
BOSTON, MA, 02116
mailing
699 BOYLSTON ST 8TH FLOOR
BOSTON, MA, 02116
Former Names
- Zalicus Inc.2014-07-02
- COMBINATORX, INC2010-08-10
- COMBINATORX INC2004-02-26